4//SEC Filing
Tegge Jonathan 4
Accession 0001213900-23-098492
CIK 0001728328other
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 1:08 PM ET
Size
5.4 KB
Accession
0001213900-23-098492
Insider Transaction Report
Form 4
Tegge Jonathan
Interim CFO
Transactions
- Award
Employee Stock Option (Right to Buy)
2023-12-23+30,000→ 31,400 totalExercise: $0.37Exp: 2028-12-22→ Common shares (30,000 underlying)
Footnotes (1)
- [F1]The options were granted on 12/23/2023 and will vest in equal installments monthly over 36 months (1/36 per month).
Documents
Issuer
InMed Pharmaceuticals Inc.
CIK 0001728328
Entity typeother
Related Parties
1- filerCIK 0001755310
Filing Metadata
- Form type
- 4
- Filed
- Dec 25, 7:00 PM ET
- Accepted
- Dec 26, 1:08 PM ET
- Size
- 5.4 KB